Filing Details

Accession Number:
0001181431-13-017950
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-19 20:55:34
Reporting Period:
2013-03-15
Filing Date:
2013-03-19
Accepted Time:
2013-03-19 20:55:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1487371 Genmark Diagnostics Inc. GNMK Surgical & Medical Instruments & Apparatus (3841) 272053069
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1134540 M Christopher Gleeson 5964 La Place Court
Carlsbad CA 92008
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-03-15 17,000 $11.93 727,993 No 4 S Indirect Gleeson Family Trust
Common Stock Disposition 2013-03-18 17,000 $11.80 710,993 No 4 S Indirect Gleeson Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Gleeson Family Trust
No 4 S Indirect Gleeson Family Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 16,854 Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in December 2012.
  2. This transaction was executed in multiple trades at prices ranging from $11.80 to $12.03. The price reported above reflects the weighted average sale price for these transactions. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the reported transactions were effected.
  3. Mr. Gleeson is the trustee of the Gleeson Family Trust and may be deemed to have beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.
  4. This transaction was executed in multiple trades at prices ranging from $11.51 to $12.18. The price reported above reflects the weighted average sale price for these transactions. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the reported transactions were effected.